Cargando…
Current and Future Treatment of Retinitis Pigmentosa
Retinitis Pigmentosa (RP) is a group of inherited retinal dystrophies (IRDs) characterised by progressive vision loss. Patients with RP experience a significant impact on daily activities, social interactions, and employment, reducing their quality of life. Frequent delays in referrals and no standa...
Autores principales: | Cross, Nancy, van Steen, Cécile, Zegaoui, Yasmina, Satherley, Andrew, Angelillo, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441588/ https://www.ncbi.nlm.nih.gov/pubmed/36071725 http://dx.doi.org/10.2147/OPTH.S370032 |
Ejemplares similares
-
Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs
por: Cross, Nancy, et al.
Publicado: (2022) -
Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases
por: Maneu, Victoria, et al.
Publicado: (2021) -
Current Concepts in the Treatment of Retinitis Pigmentosa
por: Musarella, Maria A., et al.
Publicado: (2011) -
Pharmacological strategies for treating misfolded rhodopsin-associated autosomal dominant retinitis pigmentosa
por: Xi, Yibo, et al.
Publicado: (2021) -
Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel
por: Birch, David G., et al.
Publicado: (2023)